Hairloss causes anxiety during haircuts, with some using minoxidil, finasteride, or hair transplants to cope. Others manage by cutting their own hair or accepting baldness.
Hairloss treatments discussed include cosmeRNA, minoxidil, finasteride, RU58841, and pyrilutamide. Users debate effectiveness, side effects, and upcoming treatments, with some expressing skepticism and others optimism.
Hairloss treatments discussed include Minoxidil, Finasteride, microneedling, red light therapy, and biotin pills. The most proven treatments are Minoxidil, Finasteride, and microneedling, while other methods are considered less effective or satirical.
Hairloss treatments, with users discussing their experiences with both RU58841 and Pyrilutamide, noting that the latter has only recently become available but may yield better results in the long term.
Hairloss and its potential treatments, such as minoxidil, finasteride, RU58841, dermarolling, and supplements. It discusses whether miniaturized follicles can be revived to grow again or must shed for new growth to appear.
Treating hairloss with various remedies, such as Cetirizine and the Big3 complex (minoxidil, finasteride, and RU58841), which have properties like adipogenic, anti-fibrotic and anti-inflammatory. References to research studies are also included.
PP405 is considered a potential new treatment for hairloss, compared to finasteride and minoxidil. There is skepticism about its effectiveness in humans, with anticipation for more information from an upcoming conference.
Shampoos marketed for hairloss may not effectively prevent it, as they often focus on improving hair appearance rather than addressing underlying causes like androgenetic alopecia. Effective hairloss treatment typically requires DHT blockers like finasteride.
Microneedling for hairloss, with users recommending a derma stamp over a roller to avoid scalp damage. Cleaning the derma stamp with rubbing alcohol is suggested for maintenance.
New hairloss treatments PP405 and VDPHL01 are discussed with skepticism and hope, alongside existing treatments like minoxidil and finasteride. Users express frustration over limited progress since the 1980s but remain cautiously optimistic.
A new hairloss treatment, PP405, showed promising Phase 2a results with 31% of patients experiencing over 20% hair density increase without systemic absorption, avoiding hormonal side effects. The treatment is expected to be expensive, with Phase 3 trials starting mid-2026, and there is skepticism about the data's strength.
Retinol is not effective alone for hairloss; tretinoin is more potent and sometimes mixed with minoxidil. Retinoids do not stop hairloss, and finasteride or dutasteride is necessary for that.
The user saw no hairloss improvement for a year using 1mg finasteride and 5% minoxidil. They experienced better results after reducing finasteride to 0.25mg, adding a derma pen treatment, and applying a solution with minoxidil and melatonin.
The user started a hairloss treatment with a topical solution containing 0.1% Dutasteride, 7.5% Minoxidil, 0.0125% Tretinoin, and Biotin, along with a multivitamin, Ashwagandha, CBD oil, Retinol, and Caffeine Solution. They experienced some shedding and scalp irritation, leading to a reduction in the use of the caffeine solution.
The conversation discusses hairloss treatments beyond the commonly known three, focusing on separating effective treatments from myths. Dutasteride and low-dose oral Minoxidil are mentioned as having clinical evidence for increasing hair counts, but with potential side effects.
The user experienced severe hairloss, itchy scalp, and skin issues after trying no-shampoo, and wonders if it's male pattern baldness or an immune issue. They have a history of eczema, dermatitis, and jock itch, and have tried various treatments like coconut oil, peppermint, pumpkin seed, and onion.
The user is treating hairloss with dermarolling, a laser helmet, scalp massages, and Nizoral. They stopped using minoxidil and finasteride and are considering pumpkin seed oil and sulforaphane.
A new hairloss treatment, pp405, may regrow hair better than finasteride and minoxidil, with potential availability by 2028. However, there is skepticism about its effectiveness and commercialization timeline.
People discuss various hairloss treatments, including finasteride, minoxidil, ketoconazole shampoo, biotin, vitamins, tretinoin cream, laser caps, and lifestyle changes like quitting smoking. They also mention using products like nutrafol, pumpkin seed oil, fish oil, and scalp massages.
PP405 is a potential hairloss treatment, but its safety and effectiveness are uncertain. Users advise caution and suggest waiting for more data before purchasing unverified versions.
The conversation discusses various hairloss treatments, with a focus on pyrilutamide, minoxidil, and alternatives to finasteride due to intolerance. Users suggest adding a DHT blocker like finasteride or dutasteride, and some recommend trying topical versions to reduce side effects.
Finasteride stops hairloss by blocking DHT, while Minoxidil promotes hair growth by increasing blood flow to hair follicles. Using both can help regrow hair, but results vary by individual.
The conversation is about using melatonin for hairloss, with users discussing different products and methods for topical application. They mention concerns about ingredients and cost, and one user suggests a magnesium scalp serum with melatonin.
The conversation is about hairloss treatments, with users recommending finasteride and minoxidil as effective solutions. Some users report side effects, but overall, the consensus is to use these treatments rather than waiting for a cure.
Creatine may accelerate genetic hairloss, but stopping it can reverse the effects. Finasteride helps block DHT, and some users report no issues taking both daily.
A user is using minoxidil for hairloss and considering adding finasteride but their dermatologist advised waiting to see if minoxidil works alone. They are thinking about taking saw palmetto (serenoa repens) and biotin as alternatives and are asking for others' experiences and potential side effects.